180 Wealth Advisors LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,960 shares of the healthcare conglomerate’s stock after selling 50 shares during the period. 180 Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $2,370,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. Axiom Financial Strategies LLC purchased a new stake in UnitedHealth Group in the first quarter worth $210,000. McGowan Group Asset Management Inc. increased its stake in shares of UnitedHealth Group by 8.9% in the first quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock worth $379,000 after purchasing an additional 61 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its holdings in UnitedHealth Group by 31.8% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock worth $127,592,000 after buying an additional 60,300 shares during the period. MAS Advisors LLC boosted its holdings in shares of UnitedHealth Group by 10.8% in the first quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock worth $241,000 after acquiring an additional 45 shares during the period. Finally, First Western Trust Bank bought a new stake in shares of UnitedHealth Group during the 1st quarter valued at $875,000. Hedge funds and other institutional investors own 85.69% of the company’s stock.
UnitedHealth Group Trading Down 0.1 %
Shares of UNH stock opened at $486.06 on Tuesday. The stock has a market capitalization of $450.24 billion, a PE ratio of 21.75, a P/E/G ratio of 1.43 and a beta of 0.66. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $558.10. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.80 and a quick ratio of 0.80. The business has a 50-day moving average of $492.05 and a 200 day moving average of $486.73.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Monday, September 11th will be given a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.55%. The ex-dividend date of this dividend is Friday, September 8th. UnitedHealth Group’s dividend payout ratio is currently 33.65%.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on the company. Sanford C. Bernstein upgraded UnitedHealth Group from a “market perform” rating to an “outperform” rating and upped their price target for the company from $595.00 to $603.00 in a research report on Tuesday, July 18th. Mizuho cut their price target on shares of UnitedHealth Group from $600.00 to $549.00 in a report on Tuesday, July 11th. HSBC started coverage on UnitedHealth Group in a research report on Wednesday, September 6th. They issued a “hold” rating and a $540.00 price objective on the stock. UBS Group raised their price target on UnitedHealth Group from $510.00 to $520.00 and gave the company a “neutral” rating in a report on Wednesday, July 19th. Finally, Royal Bank of Canada decreased their price objective on shares of UnitedHealth Group from $592.00 to $572.00 and set an “outperform” rating on the stock in a research report on Monday, July 17th. Two analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $575.65.
Insider Buying and Selling at UnitedHealth Group
In related news, CEO Andrew Witty sold 4,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 19th. The stock was sold at an average price of $506.19, for a total transaction of $2,024,760.00. Following the sale, the chief executive officer now directly owns 78,573 shares in the company, valued at $39,772,866.87. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.35% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
- Five stocks we like better than UnitedHealth Group
- What Is Dividend Yield and How Do You Calculate It?
- Nikola’s Stock Could Double in Price Within Weeks
- Energy and Oil Stocks Explained
- Drones Can Lift AeroVironment Shares To New Heights
- Investing in the High PE Growth Stocks
- On Holding Gets Back Into the Race After Gapping Down
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.